Incorporating Biomarkers Into Phase 2 Trials – 5 Multiple Options, Multiple Challenges
Changing Landscape of Clinical Trial Design- Small Studies, Large Differences?
November 06, 2012 | Length: 31:18 min
The copyright for all illustrations and pictures has been heeded by all authors to the best of their knowledge. If you feel your copyright has been infringed in any way or if you have any questions, do contact us by clicking on this link, please.
Innate and adaptive immunity regulated within the tumor microenvironment
Targeting Tumour-Stroma Interaction for Prevention of Metastasis
Prostate Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC): a Phase 1 Trial in Castration-Resistant Metastatic Prostate Cancer (mCRPC)
Proffered Paper Session
|Congress:||24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics|
|Category:||Clinical Trials; Biomarkers;|